Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

Microbot Medical Inc.NASDAQ: MBOT

EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026

EPS (Diluted) turns negative

Q1 FY2026 EPS (Diluted) was -$0.05, compared with $0.01 a year earlier. Trailing-twelve-month EPS (Diluted) was -$0.28.

Context

  • EPS (Diluted) grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 2 analysts of -$0.29 (+0.9%) for the fiscal year ending Dec 2026, a slowdown from the +60.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$0.05-6.0% QoQ
Last fiscal yearDec 2025
-$0.29+60.3% YoY
LTMMar 2026
-$0.28+50.9% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-996.7%+26.5%+1023.2 pp
1 year+60.3%+0.9%-59.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
(0.29) USD
Year-over-year change
+60.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How MBOT compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +50.9% is the 2nd highest of 10, against a peer median of +6.4%.
MBOT Competitors
EPS (Diluted) for MBOT and competitors
Company Period LTM YoY 3-year CAGR
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$2.58 USD+463.4%—
ZTEKZentek Ltd.LTM Mar 2026-CA$0.09 CAD+10.2%—
MBOTMicrobot Medical Inc.LTM Mar 2026-$0.28 USD+50.9%—
OVIDOvid Therapeutics Inc.LTM Mar 2026-$0.35 USD+1.2%—
CRDLCardiol Therapeutics Inc.LTM Mar 2026-CA$0.39 CAD+21.1%—
VANIVivani Medical, Inc.LTM Mar 2026-$0.4 USD+6.4%—
CNTXContext Therapeutics Inc.LTM Mar 2026-$0.42 USD-15.1%—
DCGODocGo Inc.LTM Mar 2026-$1.91 USD-16508.7%—
CLNNClene Inc.LTM Mar 2026-$3.25 USD+24.7%—
RCELAVITA Medical, Inc.LTM Mar 2026-$35.96 USD-1542.0%—
Peer median (excluding MBOT) —+6.4%—

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00106K91K0
Gross Profit00(106K)(91K)0
Gross Margin—————
Research & Development6.15M7.74M5.72M6.63M6.28M
Selling, General & Admin5.41M5.58M4.13M5M8.25M
Operating Expenses11.36M13.28M9.75M11.53M14.74M
Depreciation & Amortization76K102K106K91K47K
EBITDA(11.24M)(13.34M)(10.63M)(11.35M)(13.1M)
EBITDA Margin—————
Operating Income(11.36M)(13.28M)(9.86M)(11.63M)(14.74M)
Operating Margin—————
Interest Income44K54K228K182K1.29M
Interest Expense00000
Other Income / Expenses44K113K(885K)182K1.6M
Income Before Tax(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Net Margin—————
EPS (Basic)(1.59)(1.81)(1.05)(0.73)(0.29)
EPS (Diluted)(1.59)(1.81)(1.05)(0.73)(0.29)
Weighted Avg Shares7.11M7.26M10.2M15.65M45.79M
Weighted Avg Shares (Diluted)7.11M7.26M10.2M15.65M45.79M

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.